no code implementations • 28 Aug 2023 • Leo Fillioux, Emilie Gontran, Jérôme Cartry, Jacques RR Mathieu, Sabrina Bedja, Alice Boilève, Paul-Henry Cournède, Fanny Jaulin, Stergios Christodoulidis, Maria Vakalopoulou
In particular, PDOs are attracting interest in the field of Functional Precision Medicine (FPM), which is based upon an ex-vivo drug test in which living tumor cells (such as PDOs) from a specific patient are exposed to a panel of anti-cancer drugs.